Tipo de artículo
Condición
Encuadernación
Más atributos
Gastos de envío gratis
Ubicación del vendedor
Valoración de los vendedores
Publicado por Plenum Press, 1996
ISBN 10: 0306452944ISBN 13: 9780306452949
Librería: Zubal-Books, Since 1961, Cleveland, OH, Estados Unidos de America
Libro
Condición: Good. *Price HAS BEEN REDUCED by 10% until Monday, June 10 (weekend sale item)* 440 pp., hardcover, ex library, else text clean & binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.
Publicado por Kluwer Academic/Plenum Publishers, c1999., New York, 1999
ISBN 10: 0306461072ISBN 13: 9780306461071
Librería: Research Ink, Takoma Park, MD, Estados Unidos de America
Libro
Hardback. Condición: Very Good. viii + 271 pp. Advances in Experimental Medicine and Biology5. Rubber-stamped on front free endpaper. book.
Publicado por Kluwer Academic / Plenum Publishers, New York., 1999
ISBN 10: 0306461072ISBN 13: 9780306461071
Librería: Tiber Books, Cockeysville, MD, Estados Unidos de America
Libro
Hardcover. Condición: Very Good. 8vo, hardcover. No dj, as issued. Vg condition. Non-circulating ex-lib copy w/ label inside cover, exterior labels neatly removed (only markings); contents quite bright & clean, binding tight, covers glossy. viii, 271 p., illus. Proceedings of the Fifth Triennial Symposium on New Directions in Antiviral Chemotherapy, held November 13-15, 1997, in San Francisco, CA.
Publicado por Springer Nature B.V., 2013
ISBN 10: 1475792107ISBN 13: 9781475792102
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
Libro Impresión bajo demanda
PAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Publicado por Springer / Plenum, 1996
ISBN 10: 0306452944ISBN 13: 9780306452949
Librería: The Warm Springs Book Company, Fremont, CA, Estados Unidos de America
Libro Original o primera edición
Hardcover. Condición: Fine. 1st Edition. A fine copy issued without a DJ. Former owner's name on inside of front cover; slight trace of wear to pictorial boards; 1st edition with complete number line; illustrated; 8vo., 440 pages.
Publicado por Springer, 2013
ISBN 10: 1475792107ISBN 13: 9781475792102
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Libro
Condición: New. In.
Publicado por Springer Nature B.V., 2013
ISBN 10: 1475792107ISBN 13: 9781475792102
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
Libro Impresión bajo demanda
PAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Publicado por Springer, 1999
ISBN 10: 0306461072ISBN 13: 9780306461071
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Libro
Condición: New.
Publicado por Springer, 2012
ISBN 10: 1461371503ISBN 13: 9781461371502
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Libro
Condición: New.
Publicado por Springer, 1999
ISBN 10: 0306461072ISBN 13: 9780306461071
Librería: booksXpress, Bayonne, NJ, Estados Unidos de America
Libro
Hardcover. Condición: new.
Publicado por Springer, 2012
ISBN 10: 1461371503ISBN 13: 9781461371502
Librería: booksXpress, Bayonne, NJ, Estados Unidos de America
Libro
Soft Cover. Condición: new.
Publicado por Springer US, 2012
ISBN 10: 1461371503ISBN 13: 9781461371502
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Libro
Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
Publicado por Springer, 2012
ISBN 10: 1461371503ISBN 13: 9781461371502
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
Libro
Condición: New.
Publicado por Springer, 1999
ISBN 10: 0306461072ISBN 13: 9780306461071
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
Libro
Condición: New.
Publicado por Springer, 2012
ISBN 10: 1461371503ISBN 13: 9781461371502
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Libro Impresión bajo demanda
Condición: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Publicado por Springer, 1999
ISBN 10: 0306461072ISBN 13: 9780306461071
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Libro Impresión bajo demanda
Condición: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Publicado por Springer, 2012
ISBN 10: 1461371503ISBN 13: 9781461371502
Librería: GreatBookPricesUK, Castle Donington, DERBY, Reino Unido
Libro
Condición: New.
Publicado por Springer, 1999
ISBN 10: 0306461072ISBN 13: 9780306461071
Librería: GreatBookPricesUK, Castle Donington, DERBY, Reino Unido
Libro
Condición: New.
Publicado por Springer US Mrz 1999, 1999
ISBN 10: 0306461072ISBN 13: 9780306461071
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Libro Impresión bajo demanda
Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both. 282 pp. Englisch.
Publicado por Springer US Okt 2012, 2012
ISBN 10: 1461371503ISBN 13: 9781461371502
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Libro Impresión bajo demanda
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both. 280 pp. Englisch.
Publicado por Springer-Verlag New York Inc., 2012
ISBN 10: 1461371503ISBN 13: 9781461371502
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
Libro Impresión bajo demanda
Paperback / softback. Condición: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.
Publicado por Springer US, 1999
ISBN 10: 0306461072ISBN 13: 9780306461071
Librería: moluna, Greven, Alemania
Libro Impresión bajo demanda
Gebunden. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Scientists and clinicians attending the last New Directions in Antiviral Therapy conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretroviral.
Publicado por Springer US, 2012
ISBN 10: 1461371503ISBN 13: 9781461371502
Librería: moluna, Greven, Alemania
Libro Impresión bajo demanda
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Scientists and clinicians attending the last New Directions in Antiviral Therapy conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretroviral.
Publicado por Springer US, 1999
ISBN 10: 0306461072ISBN 13: 9780306461071
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Libro
Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
Publicado por Springer US, 2013
ISBN 10: 1475792115ISBN 13: 9781475792119
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Libro
Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of acyclovir, valacyclovir, are now licensed for VZV infections in some countries. Moreover. oral ganciclovir, cidofovir, and sorivudine are not far behind. Clinical trials with the second-site reverse transcriptase inhibitors and the protease inhibitors for HlV infection are proceeding rapidly and on a broad scale, and the preliminary results would suggest that several of these classes of drugs will be licensed as well. Despite this optimism, however, there is increasing evidence that antiviral-resistant strains of pathogenic viruses will be a significant problem, perhaps especially with therapy of HIV infection, and there remains a desperate need for improved drugs (with either improved efficacy or decreased toxicity, or both) for CMV and HIV infections. This book is the edited proceedings of the Fourth Triennial Conference on Antiviral Chemotherapy, held in San Francisco, in November 1994. The conference was sponsored by the University of California, San Francisco, and co-sponsored by the International Society for Antiviral Research (ISAR), the Macfarlane Burnet Centre for Medical Research in Melbourne, Australia, and the Australian National Centre for HIV Virology Research. The conference had been organized to present an overview of the field of antiviral chemotherapy.
Publicado por Springer, 1996
ISBN 10: 0306452944ISBN 13: 9780306452949
Librería: booksXpress, Bayonne, NJ, Estados Unidos de America
Libro
Hardcover. Condición: new.
Publicado por Springer, 2013
ISBN 10: 1475792115ISBN 13: 9781475792119
Librería: booksXpress, Bayonne, NJ, Estados Unidos de America
Libro Impresión bajo demanda
Soft Cover. Condición: new. This item is printed on demand.
Publicado por Springer-Verlag New York Inc., 2012
ISBN 10: 1461371503ISBN 13: 9781461371502
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Libro
Condición: New. Editor(s): Mills, John; Volberding, Paul A.; Corey, Lawrence. Series: Advances in Experimental Medicine and Biology. Num Pages: 271 pages, biography. BIC Classification: MF; MJCJ; MJCM; PSB. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 14. Weight in Grams: 537. . 2012. Softcover reprint of the original 1st ed. 1999. Paperback. . . . .
Publicado por Springer, 2013
ISBN 10: 1475792115ISBN 13: 9781475792119
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
Libro
Condición: New.
Publicado por Springer, 2013
ISBN 10: 1475792115ISBN 13: 9781475792119
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Libro
Condición: New.